DORZOLAMIDE and RASH

Overview

RASH is the #10 most commonly reported adverse reaction for DORZOLAMIDE, manufactured by Indoco Remedies Limited. There are 252 FDA adverse event reports linking DORZOLAMIDE to RASH. This represents approximately 1.4% of all 17,545 adverse event reports for this drug.

Patients taking DORZOLAMIDE who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

RASH is a less commonly reported adverse event for DORZOLAMIDE, but still significant enough to appear in the safety profile.

Other Side Effects of DORZOLAMIDE

In addition to rash, the following adverse reactions have been reported for DORZOLAMIDE:

• TREATMENT FAILURE — 1,369 reports
• DRUG INEFFECTIVE — 705 reports
• OFF LABEL USE — 475 reports
• FATIGUE — 444 reports
• HEADACHE — 356 reports
• PAIN — 321 reports
• EYE PAIN — 292 reports
• EYE IRRITATION — 281 reports
• HYPERSENSITIVITY — 265 reports
• PAIN IN EXTREMITY — 250 reports

Other Drugs Associated with RASH

The following drugs have also been linked to rash in FDA adverse event reports:

Does DORZOLAMIDE cause RASH?

RASH has been reported as an adverse event in 252 FDA reports for DORZOLAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is RASH with DORZOLAMIDE?

RASH accounts for approximately 1.4% of all adverse event reports for DORZOLAMIDE, making it a notable side effect.

What should I do if I experience RASH while taking DORZOLAMIDE?

If you experience rash while taking DORZOLAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages